4th Amendment to Lincolnshire lease
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
__________________
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
__________________
Date
of
Report (Date of earliest event reported):
March
2, 2007
BIOSANTE
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
001-31812
|
58-2301143
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification Number)
|
111
Barclay Boulevard
Lincolnshire,
Illinois
|
60069
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(847)
478-0500
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
£ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Section
1 —
Registrant’s Business and Operations
Item
1.01 Entry into a Material Definitive Agreement.
On
March
2, 2007, BioSante Pharmaceuticals, Inc. entered into a Fourth Amendment to
the
Lease with LaSalle Bank National Association, as successor trustee to American
National Bank and Trust Company of Chicago effective as of March 7, 2007. The
Fourth Amendment amends the Lease, dated as of December 19, 2003, as amended,
between BioSante and LaSalle Bank National Association. The Amendment is filed
as Exhibit 10.1 to this report and is incorporated herein by this
reference.
The
Amendment, among other things, extended the term of the Lease, as amended,
from
March 21, 2007 to March 21, 2008 and increased the annual base rent from
approximately $88,000 per year to $90,000 per year.
Section
9 — Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits
(d) |
Exhibits.
The following exhibit is filed
herewith:
|
Exhibit
No.
|
Description
|
|
Fourth
Amendment to Lease dated as of March 7, 2007, by and between BioSante
Pharmaceuticals, Inc. and LaSalle Bank National Association, as successor
trustee to American National Bank and Trust Company of
Chicago.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
BIOSANTE
PHARMACEUTICALS, INC.
By:
/s/
Phillip B. Donenberg
Phillip
B. Donenberg
Chief
Financial Officer, Treasurer and Secretary
Dated:
March
7,
2007
BIOSANTE
PHARMACEUTICALS, INC.
FORM
8-K
EXHIBIT
INDEX
Exhibit
No. Description
10.1 Fourth
Amendment to Lease dated as of March 7, 2007, by and between BioSante
Pharmaceuticals, Inc. and LaSalle Bank National Association, as successor
trustee to American National Bank and Trust Company of
Chicago.